With media solemnly spotlighting the passing of the 200,000 mark in deaths attributed to COVID-19 in the United States, a physicians assocation has a question.
The reference is to a country-based analysis updated Sept. 20 that shows a gap between countries that treat COVID-19 early or prophylactically with hydroxychloroquine and those that, like the U.S., discourage or prohibit its use.
The answer to Orient's question can be found in a white paper published by the Economic Standard this month titled "Hydroxychloroquine and the Burden of Proof: An Urgent Call to Depoliticize Medicine in the COVID-19 Pandemic."
"The COVID-19 pandemic struck America nine months before a presidential election, turning basic medical activities like testing and treatment into partisan battlegrounds," writes Economic Standard Editor-in-Chief Erik Sass in the overview.
Should hydroxychloroquine be used to help battle coronavirus?
"Right now, doctors around the world are prescribing HCQ to treat COVID-19 outside of hospitals, as well as prophylactically to prevent infection among healthcare workers and vulnerable populations."
The paper argues that hydroxychloroquine "Has met the appropriate burden of proof and urges members of the U.S. news media, public health community, and regulatory agencies to stop politicizing the use of this medicine."
https://www.wnd.com/2020/09/coronavirus-deaths-75-lower-nations-using-hydroxychloroquine/
No comments:
Post a Comment